Literature DB >> 26041959

Diagnosis of minimal hepatic encephalopathy.

Karin Weissenborn1.   

Abstract

Minimal hepatic encephalopathy (mHE) has significant impact upon a liver patient's daily living and health related quality of life. Therefore a majority of clinicians agree that mHE should be diagnosed and treated. The optimal means for diagnosing mHE, however, is controversial. This paper describes the currently most frequently used methods-EEG, critical flicker frequency, Continuous Reaction time Test, Inhibitory Control Test, computerized test batteries such as the Cognitive Drug Research test battery, the psychometric hepatic encephalopathy score (PHES) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)-and their pros and cons.

Entities:  

Keywords:  CDR, cognitive drug research; CFF, critical flicker frequency; CRT, continuous reaction time test; EEG, electroencephalography; ICT, inhibitory control test; PHES, psychometric hepatic encephalopathy score; PSE, portosystemic encephalopathy; RBANS, repeatable battery for the assessment of neuropsychological status; TA, target accuracy; WL, weighted lures; diagnostic means; diagnostic use; mHE, minimal hepatic encephalopathy; minimal hepatic encephalopathy; sensitivity; specificity

Year:  2014        PMID: 26041959      PMCID: PMC4442856          DOI: 10.1016/j.jceh.2014.06.005

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  47 in total

1.  Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

Authors:  Gerald Kircheis; Matthias Wettstein; Lars Timmermann; Alfons Schnitzler; Dieter Häussinger
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

2.  Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study.

Authors:  Piero Amodio; Francesca Campagna; Stefania Olianas; Pamela Iannizzi; Daniela Mapelli; Marco Penzo; Paolo Angeli; Angelo Gatta
Journal:  J Hepatol       Date:  2008-06-02       Impact factor: 25.083

3.  Improving the inhibitory control task to detect minimal hepatic encephalopathy.

Authors:  Piero Amodio; Lorenzo Ridola; Sami Schiff; Sara Montagnese; Chiara Pasquale; Silvia Nardelli; Ilaria Pentassuglio; Maria Trezza; Chiara Marzano; Cristiana Flaiban; Paolo Angeli; Giorgia Cona; Patrizia Bisiacchi; Angelo Gatta; Oliviero Riggio
Journal:  Gastroenterology       Date:  2010-05-11       Impact factor: 22.682

4.  Smart applications for assessing minimal hepatic encephalopathy: novelty from the app revolution.

Authors:  Piero Amodio; Juan Cordoba
Journal:  Hepatology       Date:  2013-07-29       Impact factor: 17.425

5.  A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy.

Authors:  Oliviero Riggio; Lorenzo Ridola; Chiara Pasquale; Ilaria Pentassuglio; Silvia Nardelli; Federica Moscucci; Manuela Merli; Sara Montagnese; Piero Amodio; Carlo Merkel
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-24       Impact factor: 11.382

6.  Neuropsychological aspects of portal-systemic encephalopathy.

Authors:  H Schomerus; W Hamster
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

7.  Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis.

Authors:  Mette Munk Lauridsen; Henning Grønbæk; Esben B Næser; Steffen T Leth; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2012-05-22       Impact factor: 3.584

8.  Utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in patients with end-stage liver disease awaiting liver transplant.

Authors:  Scott Mooney; Tarek I Hasssanein; Robin C Hilsabeck; Elizabeth A Ziegler; Meghan Carlson; Leeza M Maron; William Perry
Journal:  Arch Clin Neuropsychol       Date:  2007-02-05       Impact factor: 2.813

9.  Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.

Authors:  Yeon Seok Seo; Sun Young Yim; Jin Yong Jung; Chang Ha Kim; Jin Dong Kim; Bora Keum; Hyonggin An; Hyung Joon Yim; Hong Sik Lee; Chang Duck Kim; Ho Sang Ryu; Soon Ho Um
Journal:  J Gastroenterol Hepatol       Date:  2012-11       Impact factor: 4.029

10.  Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation.

Authors:  Gerald Kircheis; Johannes G Bode; Norbert Hilger; Thomas Kramer; Alfons Schnitzler; Dieter Häussinger
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-12       Impact factor: 2.566

View more
  20 in total

1.  Canadian regulations and legal ramifications for hepatic encephalopathy: a descriptive analysis.

Authors:  Henry H Nguyen; Mark G Swain; Philip Wong; Stephen E Congly
Journal:  CMAJ Open       Date:  2018-12-03

2.  Differences in cognitive function between patients with viral and alcoholic compensated liver cirrhosis.

Authors:  Yunhyeong Lee; Chulho Kim; Ki Tae Suk; Hui Chul Choi; Chang Seok Bang; Jai Hoon Yoon; Gwang Ho Baik; Dong Joon Kim; Min Uk Jang; Jong Hee Sohn
Journal:  Metab Brain Dis       Date:  2015-11-12       Impact factor: 3.584

Review 3.  Overview of Complications in Cirrhosis.

Authors:  Madhumita Premkumar; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2022-05-14

Review 4.  Encephalopathy in Cirrhosis: Prevention and Management.

Authors:  Amrish Sahney; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2021-12-22

5.  Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).

Authors:  Mircea Alexandru Badea; Vasile Liviu Drug; Mihaela Dranga; Otilia Gavrilescu; Gabriela Stefanescu; Iolanda Popa; Catalina Mihai; Cristina Cijevschi-Prelipcean
Journal:  Metab Brain Dis       Date:  2016-07-27       Impact factor: 3.584

Review 6.  Qualifying and quantifying minimal hepatic encephalopathy.

Authors:  Marsha Y Morgan; Piero Amodio; Nicola A Cook; Clive D Jackson; Gerald Kircheis; Mette M Lauridsen; Sara Montagnese; Sami Schiff; Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2015-09-28       Impact factor: 3.584

7.  Validation of a Paper and Pencil Test Battery for the Diagnosis of Minimal Hepatic Encephalopathy in Korea.

Authors:  Jae Yoon Jeong; Dae Won Jun; Daiseg Bai; Ji Yean Kim; Joo Hyun Sohn; Sang Bong Ahn; Sang Gyune Kim; Tae Yeob Kim; Hyoung Su Kim; Soung Won Jeong; Yong Kyun Cho; Do Seon Song; Hee Yeon Kim; Young Kul Jung; Eileen L Yoon
Journal:  J Korean Med Sci       Date:  2017-09       Impact factor: 2.153

8.  Central nervous system manganese induced lesions and clinical consequences in patients with hereditary hemorrhagic telangiectasia.

Authors:  M M Serra; C H Besada; A Cabana Cal; A Saenz; C V Stefani; D Bauso; A B Golimstok; J C Bandi; D H Giunta; C M Elizondo
Journal:  Orphanet J Rare Dis       Date:  2017-05-18       Impact factor: 4.123

9.  Frequency of minimal hepatic encepalopathy in illeterate patients with compensated cirrhosis.

Authors:  Bader Faiyaz Zuberi; Haris Alvi; Faisal Faiyaz Zuberi; Tazeen Rasheed; Zunaira Nawaz
Journal:  Pak J Med Sci       Date:  2016 May-Jun       Impact factor: 1.088

10.  Normalisation of the psychometric encephalopathy score within the Cameroonian population.

Authors:  Larissa Pessidjo Djomatcho; Mathurin Pierre Kowo; Antonin Ndjitoyap Ndam; Sylvain Raoul Simeni Njonnou; Gabin Ulrich Kenfack; Firmin Ankouane Andoulo; Servais Fiacre Eloumou Bagnaka; Winnie Tatiana Bekolo; Agnès Malongue; Isabelle Dang Babagna; Magloire Biwolé Sida; Henry Luma; Oudou Njoya
Journal:  BMC Gastroenterol       Date:  2021-07-12       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.